SCHEMBL17437313

SCHEMBL17437313

Nc1ncnn1-c1nc2cncc(-c3ccccc3F)c2n1-c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CYP1A2 P05177 8/20 0.34
▸ USP2 O75604 6/20 0.34
▸ CYP2C9 P11712 6/20 0.34
▸ CYP2C19 P33261 6/20 0.34
▸ CYP3A4 P08684 5/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ HSD17B10 Q99714 5/20 0.34
▸ MAPK1 P28482 3/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ TSHR P16473 3/20 0.32
▸ KDM4E B2RXH2 2/20 0.31
▸ EGFR P00533 1/20 0.31
▸ PI4KA P42356 1/20 0.31
▸ PI4K2B Q8TCG2 1/20 0.31
▸ PI4K2A Q9BTU6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437482 0.88 MEN1 (0.33) MAPTCYP1A2USP2CYP2C9CYP2C19
SCHEMBL17437512 0.84 CYP11B2 (0.34) ADORA2AEGLN2
SCHEMBL17437382 0.83 USP2 (0.36) CYP1A2USP2CYP2C9CYP2C19CYP3A4
SCHEMBL17437328 0.82 CYP1A2 (0.35) MAPTNPSR1CYP1A2USP2CYP2C9
SCHEMBL17437460 0.82 RPS6KA5 (0.34) CYP1A2ADORA2ACYP2D6EGLN2
SCHEMBL17437529 0.81 CYP11B2 (0.37) CYP1A2CYP2C19CYP3A4ALDH1A1TSHR
SCHEMBL17437312 0.81 KDM4E (0.34) MAPTKMT2AMEN1ADORA2AMAPK1
SCHEMBL17437573 0.80 TLR8 (0.36) ADORA2AHSD17B10MAPK1ALDH1A1
SCHEMBL17437317 0.79 ALDH1A1 (0.33) MAPTCYP1A2USP2CYP2C9CYP2C19
SCHEMBL17437386 0.76 RPS6KA5 (0.49) CYP1A2USP2CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 MAPT 3817/4885NPSR1 1785/4885CYP1A2 25/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 MAPT 3817/4885NPSR1 1785/4885CYP1A2 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback